Clinical trials: DEB-TACE

Hepatocellular Carcinoma

Role of DEB-TACE Versus c-TACE in Treatment of HCC

• Unknown status
• Age: All ages
• Early Phase 1

Hepatocellular carcinoma (HCC) is listed as the sixth most common cancer worldwide and the third most frequent cause of cancer-related mortality. The majority of HCC cases occurs stem from chronic liver disease and cirrhosis.

Trial name

NCT05093920

Testing

Doxorubicin-Eluting Beads

Where

Egypt

Volunteers

30 people

Sponsor

Sohag University